Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 283,610 | 276,774 | 245,965 | 247,053 | 184,052 |
| Marketable Securities | 210,016 | 207,841 | 207,845 | 157,173 | 141,838 |
| Receivables | 104,745 | 113,304 | 100,653 | 104,779 | 101,639 |
| Inventories | 133,754 | 125,282 | 111,865 | 103,438 | 96,782 |
| TOTAL | $759,962 | $745,130 | $689,969 | $632,214 | $543,113 |
| Non-Current Assets | |||||
| PPE Net | 164,451 | 167,169 | 166,852 | 168,850 | 171,804 |
| Investments And Advances | 28,031 | 35,649 | 0 | 0 | 36,542 |
| Intangibles | 456,489 | 425,970 | 440,292 | 617,857 | 632,179 |
| Other Non-Current Assets | 177,736 | 179,598 | 224,578 | 227,899 | 199,683 |
| TOTAL | $826,707 | $808,386 | $831,722 | $1,014,606 | $1,040,208 |
| Total Assets | $1,586,669 | $1,553,516 | $1,521,691 | $1,646,820 | $1,583,321 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 202,086 | 201,776 | 201,466 | N/A | 8,641 |
| Accounts payable and accrued liabilities | 23,172 | 19,133 | 19,367 | 18,730 | 8,982 |
| Accrued Expenses | 80,069 | 80,124 | 76,377 | 64,811 | 66,818 |
| TOTAL | $314,732 | $309,920 | $306,401 | $92,690 | $93,444 |
| Non-Current Liabilities | |||||
| Long Term Debt | 101,489 | 383,545 | 107,024 | 109,751 | 112,477 |
| Other Non-Current Liabilities | 364,911 | 81,703 | 358,683 | 565,101 | 485,238 |
| TOTAL | $473,396 | $465,248 | $465,707 | $674,852 | $597,715 |
| Total Liabilities | $788,128 | $775,168 | $772,108 | $767,542 | $691,159 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,305 | 46,276 | 46,173 | 46,127 | 46,546 |
| Common Shares | 47 | 47 | 47 | 47 | 47 |
| Retained earnings | -201,544 | -206,356 | -222,397 | -78,931 | -97,817 |
| Other shareholders' equity | 1,230 | 222 | 557 | -16 | 152 |
| TOTAL | $798,541 | $778,348 | $749,583 | $879,278 | $892,162 |
| Total Liabilities And Equity | $1,586,669 | $1,553,516 | $1,521,691 | $1,646,820 | $1,583,321 |